Release Date: 17/02/12 08:35 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 318.97KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%